(Q38704400)

5 September 2017

1 reference

title

Mucormycosis: association with deferoxamine therapy (English)

1 reference

5 September 2017

1 reference

Daly AL

1

1 reference

5 September 2017

Velazquez LA

series ordinal

2

1 reference

5 September 2017

Bradley SF

series ordinal

3

1 reference

5 September 2017

Kauffman CA

series ordinal

4

1 reference

5 September 2017

language of work or name

English

0 references

publication date

1 October 1989

1 reference

American Journal of Medicine

5 September 2017

published in

1 reference

5 September 2017

volume

87

1 reference

5 September 2017

issue

4

1 reference

5 September 2017

page(s)

468-471

1 reference

The changing spectrum of disease, etiology, and diagnosis of mucormycosis

5 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Improved diagnosis and prognosis of mucormycosis. A clinicopathologic study of 33 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Cardiac mucormycosis. A report of five patients and review of 14 previously reported cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Cunninghamella: a newly recognized cause of rhinocerebral mucormycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Disseminated infection caused by Cunninghamella bertholletiae in a patient with beta-thalassemia. Case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Myocardial mucormycosis with emboli in a hemodialysis patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Intestinal mucormycosis in hemodialysis patients following deferoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Mucormycosis in deferoxamine-treated patients on dialysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Fatal phycomycosis in a hemodialyzed patient receiving deferoxamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Bilateral Cavernous Sinus Thrombosis due to Mucormycosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Cunninghamella bertholletiae infection associated with deferoxamine therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Deferoxamine treatment as a risk factor for zygomycete infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Mucormycotic slough of nasal floor and palate in the anephric patient

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Wound zygomycosis (mucormycosis) in otherwise healthy adults

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Specific susceptibility to mucormycosis in murine diabetes and bronchoalveolar macrophage defense against Rhizopus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Phycomycosis complicating leukemia and lymphoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

7 January 2021

Infections and Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Iron and virulence in the family Enterobacteriaceae

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Listeriosis in patients with long-term hemodialysis and transfusional iron overload.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

Azole antifungal agents: emphasis on new triazoles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9343%2889%2980836-8

10.1016/S0002-9343(89)80836-8

7 January 2021

Identifiers

DOI

1 reference

5 September 2017

1 reference